Episode Summary
Executive Summary: Peter Attia opens by explaining the podcast’s ad-free, listener-supported model, then interviews Dr. Jason Fung on evidence-based medicine, kidney disease, insulin resistance, and fasting. Fung argues that type 2 diabetes and metabolic syndrome are better understood as hyperinsulinemia/overflow states than classic insulin resistance, and that fasting and carbohydrate restriction can reverse disease by emptying excess glucose and fat from the body.
Main Topics: Ad-free, listener-supported podcast model (Priority: 3/5): Attia explains why the show avoids ads: to preserve trust, maintain honesty, and fund higher-quality show notes, transcripts, AMAs, and member benefits through subscriptions. Evidence-based medicine vs. clinical/theoretical reasoning (Priority: 5/5): Attia and Fung contrast medicine’s consensus-driven pace with physics’ theory-plus-experiment model, arguing that biology needs more room for mechanistic reasoning and bedside observation. Why nephrology matters for metabolic disease (Priority: 4/5): Fung explains that kidney disease is a useful window into early metabolic injury because the kidneys filter huge blood volumes and show early signs like albuminuria, hypertension, and declining function. Reframing insulin resistance as hyperinsulinemia/overflow (Priority: 5/5): The central thesis is that the conventional lock-and-key model is incomplete; Fung argues the real problem is too much insulin and too much intracellular glucose/fat, creating an overflow state rather than cellular starvation. Type 2 diabetes, NAFLD, and beta-cell dysfunction as one process (Priority: 5/5): Fung links fatty liver, fatty pancreas, rising insulin, and eventual beta-cell failure into a single reversible pathophysiology, with NAFLD and diabetes reinforcing each other in a vicious cycle. Fasting and dietary restriction as treatment (Priority: 5/5): The discussion moves to practical therapy: time-restricted feeding, low-carb diets, and especially intermittent/longer fasting as ways to lower insulin, mobilize stored fuel, and reverse metabolic disease. Broader implications for growth, cancer, and longevity (Priority: 4/5): Fung and Attia connect insulin, mTOR, AMPK, obesity, cardiovascular disease, and cancer as diseases of excessive growth, suggesting fasting may have benefits beyond diabetes management.
Key Arguments: The conventional insulin-resistance model is internally inconsistent because insulin’s other actions—lipogenesis, growth signaling, sodium retention—remain highly active in type 2 diabetes. Hyperinsulinemia is a better unifying explanation than insulin resistance because it accounts for obesity, high triglycerides, low HDL, hypertension, NAFLD, PCOS, and cancer risk. Type 2 diabetes is not simply beta-cell failure; it is a reversible process in many patients, especially when liver and pancreatic fat are reduced. SGLT2 inhibitors work well because they remove glucose from the body rather than forcing more insulin into an already overloaded system. Fasting is the most potent way to lower insulin and can reverse severe diabetes quickly, especially when paired with close clinical supervision. Exercise helps by increasing glucose disposal, but it is less efficient than dietary restriction or fasting for reversing fatty liver and hyperinsulinemia. Obesity may be partly protective in the short term because adipose tissue buffers excess energy; the deeper problem is excess glucose/insulin overflow. Inflammation may interact with metabolic disease, but Fung sees insulin/cortisol/growth signaling as more actionable and mechanistically clear. Many chronic diseases should be viewed as disorders of excessive growth, linking insulin and mTOR to cardiovascular disease, cancer, and aging. Clinical observation and patient response should matter more than rigid consensus when evidence is incomplete or slow to emerge.
Data Points: Podcast funding model: 100% listener-supported, no ads - Attia explains the show relies entirely on subscriptions rather than advertising. Kidney blood flow: ~20% of total body circulation - Fung describes why the kidney is an early indicator of systemic metabolic injury. Urine filtration vs output: ~10x more filtered than excreted as urine - Used to illustrate the kidney’s high-throughput filtering role. Albuminuria marker: Albumin-to-creatinine ratio - Attia highlights this as a practical marker of early kidney and vascular damage. ADA guideline shift: Low-carbohydrate diets now described as having the most evidence behind them - Attia and Fung note how quickly official guidance has changed. Type 2 diabetes reversal after bariatric surgery: ~80%–90% off medications - Fung cites bariatric surgery outcomes as evidence that diabetes can be reversed. SGLT2 kidney protection: ~25% reduction in kidney disease risk - Fung cites trial results showing organ protection despite modest A1c changes. SGLT2 glycemic effect: A1c drop of ~0.3–0.4 - Used to argue that benefits are not explained by glucose lowering alone. Insulin infusion study: 0 to 100 units over 6 months - Fung cites a trial where giving insulin caused weight gain despite improved glucose. Weight gain with insulin: ~20 pounds - Observed in the insulin-treated type 2 diabetes trial. Calorie intake change with insulin: Down ~200–300 calories/day - Shows weight gain occurred despite lower reported intake. Case series response: Insulin stopped in 5 to 18 days - Three severe type 2 diabetes patients improved rapidly on fasting/low-carb intervention. Long fast example: 61 days - A patient in her 80s reportedly completed a prolonged fast under monitoring. Diabetic foot ulcer healing: ~3 weeks - A severe ulcer improved rapidly after aggressive fasting-based treatment. A1c after treatment: 5.9 - The diabetic foot ulcer patient later reached non-diabetic range. Breakfast study concern: Higher cardiac mortality in breakfast skippers - Attia and Fung criticize nutritional epidemiology and confounding. Typical fasting baseline in the 1970s: ~14 hours overnight - Used to argue that modern eating windows have expanded unnaturally. Current eating window in some populations: ~15 hours/day - Attia cites Sachin Panda’s work on prolonged daily eating duration. Meal count comparison: 15 meals out of 1,000 - Fung argues a 5-day fast per year is low risk relative to annual intake.
Pivotal Quotes: "The problem is not insulin resistance per se. The problem is hyperinsulinemia." — Jason Fung: Core reframing of the metabolic disease model during the insulin discussion. "It’s not an underfill problem. It’s an overflow problem." — Jason Fung: Explains why cells appear resistant: they are already overloaded, not starved. "Evidence-based medicine is good if you know how to apply it. The whole point of evidence-based medicine is that it’s not a search for truth. It’s a search for consensus." — Peter Attia: Attia’s critique of how medicine can lag behind mechanistic insight.
Implications: The episode argues for a major shift in metabolic medicine: treat excess insulin and fuel overload directly, use fasting and carbohydrate restriction more boldly, and judge interventions by clinical effect, not consensus alone. It also broadens fasting from weight loss to longevity and chronic disease prevention.
About Peter Attia Drive
Expert insight on health, performance, longevity, critical thinking, and pursuing excellence. Dr. Peter Attia (Stanford/Hopkins/NIH-trained MD) talks with leaders in their fields.